KYMR (KYMR) Form 144 shows Atlas Venture and Bruce Booth proposed sales

robot
Abstract generation in progress

Kymera Therapeutics (KYMR) has filed Form 144 notices detailing proposed sales of Common Stock by affiliated holders, including Atlas Venture Fund X, Atlas Venture Opportunity Fund I, and Bruce Booth. Atlas Venture Fund X plans to sell 71,814 shares, with other entities and individuals also proposing sales on various dates in March and April 2026. The filing indicates a “Neutral” impact and sentiment for the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin